Printer Friendly

CSX CORPORATION NAMES DR. FRANK S. ROYAL TO BOARD OF DIRECTORS

 RICHMOND, Va., Dec. 8 /PRNewswire/ -- CSX Corporation (NYSE: CSX) announced today that Frank S. Royal, M.D., a prominent Richmond physician, academic leader and health care executive, has been elected to the company's board of directors.
 Royal, 54, a native of Lynchburg, Va., began his private practice in family medicine in 1969. Prior to entering medical school and beginning his practice, he was a teacher in Lynchburg and Richmond public schools.
 Speaking on behalf of the CSX board, John W. Snow, chairman and chief executive officer of CSX Corporation, said, "We are pleased Dr. Royal has agreed to join our board and look forward to working with him as we continue to build this company and further the best interests of our shareholders, customers, employees and the communities we serve."
 Royal also serves on the board of directors of Hospital Corporation of America, Crestar Financial Corporation and Chesapeake Corporation. He is chairman of the board of Meharry Medical College in Nashville, Tenn., and chairman of the board of trustees of Virginia Union University in Richmond. Royal also is a member of the board of trustees of Richmond Community Hospital, a member of the board of associates of the University of Richmond, and an assistant clinical professor of family practice at the Medical College of Virginia.
 CSX Corporation, headquartered in Richmond, is an international transportation company offering a variety of rail, container-shipping, intermodal, trucking and barge services.
 -0- 12/8/93
 /CONTACT: Thomas E. Hoppin or Suzanne S. Walston of CSX, 804-782-1406/
 (CSX)


CO: CSX Corporation ST: Virginia IN: TRN SU: PER

IH-DC -- DC005 -- 1685 12/08/93 10:31 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 8, 1993
Words:270
Previous Article:MICROCARB NAMES VACCINE ADVISORY BOARD
Next Article:CONGRESSIONAL QUARTERLY RELEASES SPECIAL REPORT ANALYZING ALL 13 FY'94 CONGRESSIONAL APPROPRIATIONS BILLS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters